newdrugapprovals.org
Pemafibrate, Пемафибрат , بيرمافيبرات , 佩玛贝特 , ペマフィブラート ,
Pemafibrate NDA Filing Japan, Phase 2 in EU, US A PPAR-α agonist potentially for the treatment of dyslipidemia. K-877, K-13675, (R)- CAS No. 848259-27-8, Molecular Formula,C28-H30-N2-…